| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PARR | United States | $55.66 | $2,443,066,000.00 | Buy | 6 | 2000 |
#2 | AR | United States | $35.62 | $5,275,823,000.00 | Buy | 16 | 2013 |
#3 | INVA | United States | $21.31 | $217,217,000.00 | Buy | 5 | 2000 |
#4 | EQT | United States | $54.61 | $8,644,211,000.00 | Buy | 21 | 1994 |
#5 | NFG | United States | $77.12 | $2,277,541,000.00 | Buy | 4 | 1997 |
#6 | CVNA | United States | $73.02 | $20,322,000,000.00 | Buy | 24 | 2017 |
#7 | TMDX | United States | $66.87 | $605,494,000.00 | Buy | 9 | 2019 |
#8 | DEC | United States | $14.54 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#9 | CECO | United States | $75.10 | $0.00 | Strong Buy | 4 | 2002 |
#10 | TBPH | United States | $16.05 | $15,386,000.00 | Buy | 6 | 2013 |
#11 | KNSA | United Kingdom | $48.37 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#12 | VIAV | United States | $48.55 | $1,084,300,000.00 | Strong Buy | 8 | 1996 |
#13 | EYE | United States | $16.80 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#14 | VTR | United States | $84.69 | $5,833,980,000.00 | Buy | 13 | 2005 |
#15 | AORT | United States | $22.25 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#16 | KNTK | United States | $45.97 | $160,617,000.00 | Buy | 12 | 2017 |
#17 | APEI | United States | $49.47 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#18 | SWX | United States | $86.34 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#19 | NVST | United States | $23.64 | $2,566,500,000.00 | Buy | 13 | 2019 |
#20 | PUMP | United States | $15.06 | $1,269,158,000.00 | Buy | 7 | 2017 |
#21 | ALHC | United States | $15.35 | $3,948,719,000.00 | Buy | 8 | 2021 |
#22 | NMRK | United States | $13.94 | $3,294,024,000.00 | Buy | 5 | 2017 |
#23 | OMER | United States | $11.11 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#24 | STOK | United States | $30.89 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#25 | ANAB | United States | $55.71 | $234,603,000.00 | Buy | 12 | 2015 |
#26 | PTEN | United States | $11.17 | $4,826,624,000.00 | Buy | 10 | 1995 |
#27 | CCK | United States | $95.33 | $11,665,000,000.00 | Buy | 16 | 2003 |
#28 | REPX | United States | $33.37 | $3,038,000.00 | Strong Buy | 4 | 2003 |
#29 | AROC | United States | $33.58 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#30 | PRVA | United States | $21.51 | $2,122,842,000.00 | Buy | 12 | 2021 |
#31 | LASR | United States | $73.45 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#32 | KGS | United States | $67.01 | $1,308,100,000.00 | Strong Buy | 7 | 2023 |
#33 | BSX | United States | $48.38 | $9,076,000,000.00 | Strong Buy | 22 | 2010 |
#34 | CSV | United States | $41.38 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#35 | SDRL | United States | $46.91 | $1,437,000,000.00 | Buy | 4 | 2018 |
#36 | HCSG | United States | $20.61 | $1,837,173,000.00 | Buy | 6 | 1994 |
#37 | HG | Bermuda | $29.47 | $2,905,524,000.00 | Buy | 8 | 2023 |
#38 | PAY | United States | $23.37 | $1,196,507,000.00 | Buy | 8 | 2021 |
#39 | TARS | United States | $59.00 | $451,360,000.00 | Buy | 6 | 2020 |
#40 | CRVS | United States | $12.35 | $0.00 | Strong Buy | 6 | 2016 |
#41 | USFD | United States | $81.98 | $39,424,000,000.00 | Buy | 11 | 2016 |
#42 | MAMA | United States | $13.83 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#43 | BFAM | United States | $62.87 | $1,903,182,000.00 | Buy | 7 | 2012 |
#44 | ERAS | United States | $12.79 | $0.00 | Strong Buy | 12 | 2021 |
#45 | PPL | United States | $35.33 | $9,042,000,000.00 | Buy | 13 | 2007 |
#46 | MDT | Ireland | $74.07 | $33,537,000,000.00 | Buy | 21 | 2014 |
#47 | LMAT | United States | $94.67 | $249,602,000.00 | Buy | 5 | 2006 |
#48 | ENTA | United States | $13.27 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#49 | CE | United States | $52.65 | $9,544,000,000.00 | Buy | 14 | 2004 |
#50 | FTI | United States | $68.56 | $9,932,600,000.00 | Buy | 13 | 2016 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 31, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.